Use fundamental data analysis to double-check all available reported financial drivers of CVS Health to find out if markets are now mispricing the company. We found thirty-eight available fundamental indicators for CVS Health Corporation which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all CVS Health fundamentals including its Revenue, Cash Flow from Operations, Current Asset, as well as the relationship between Cash per Share and Beta . Given that CVS Health has Price to Earning of 24.13X, we suggest you validate CVS Health Corporation prevailing market performance to make sure the company can sustain itself next year.Use CVS Health to protect against small markets fluctuations. The stock experiences unexpected downward movement. The market is reacting to new fundamentals. Check odds of CVS Health to be traded at $66.21 in 30 days
CVS Health Company Summary
CVS Health competes with Cigna, Express Scripts, Centene, Humana, and Molina Healthcare. CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island. CVS Health operates under Health Care Plans classification in USA and is traded on BATS Exchange. It employs 160000 people.
CVS Health Net Income vs Price to Sales
CVS Health Corporation is rated fifth in net income category among related companies. It is rated below average in price to sales category among related companies . The ratio of Net Income to Price to Sales for CVS Health Corporation is about 6,200,000,000
|Price to Sales ( times )|
CVS Health Systematic Risk